Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B with Atherosclerosis in Adults with Type 1 Diabetes Mellitus

American Journal of Cardiology

Volumn 116, Issue 7, 2015, Pages 1057-1062

  Bjornstad, Petter ^a,b   Eckel, Robert H ^b   Pyle, Laura ^a   Rewers, Marian ^a,b   Maahs, David M ^a,b   Snell Bergeon, Janet K ^a,b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL DERIVATIVE; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ATHEROSCLEROSIS; BLOOD; BODY MASS; CALCINOSIS; COMPLICATION; CORONARY ARTERY DISEASE; FOLLOW UP; INCIDENCE; MIDDLE AGED; RISK FACTOR; TIME; UNITED STATES; YOUNG ADULT;

ADULT; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOMARKERS; BODY MASS INDEX; CALCINOSIS; CHOLESTEROL, HDL; COLORADO; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84941192506     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.07.020     Document Type: Article

References (28)

1. V. Ramjee, L.S. Sperling, and T.A. Jacobson Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math J Am Coll Cardiol 58 2011 457 463
2. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, and E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033
3. M.J. McQueen, S. Hawken, X. Wang, S. Ounpuu, A. Sniderman, J. Probstfield, K. Steyn, J.E. Sanderson, M. Hasani, E. Volkova, K. Kazmi, and S. Yusuf Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Lancet 372 2008 224 233
4. J.J. Albers, A. Slee, K.D. O'Brien, J.G. Robinson, M.L. Kashyap, P.O. Kwiterovich Jr., P. Xu, and S.M. Marcovina Relationship of apolipoproteins A-1 and B, and lipoprotein (a) to cardiovascular outcomes: the AIM-High Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes) J Am Coll Cardiol 62 2013 1575 1579
5. M. Juonala, J.S. Viikari, M. Kahonen, T. Solakivi, H. Helenius, A. Jula, J. Marniemi, L. Taittonen, T. Laitinen, T. Nikkari, and O.T. Raitakari Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study J Am Coll Cardiol 52 2008 293 299
6. A. Sniderman, K. Williams, and J. de Graaf Non-HDL C equals apolipoprotein B: except when it does not! Curr Opin Lipidol 21 2010 518 524
7. P. Bjornstad, D.M. Maahs, R.P. Wadwa, L. Pyle, M. Rewers, R.H. Eckel, and J.K. Snell-Bergeon Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study J Clin Lipidol 8 2014 576 583
8. I.E. Schauer, J.K. Snell-Bergeon, B.C. Bergman, D.M. Maahs, A. Kretowski, R.H. Eckel, and M. Rewers Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study Diabetes 60 2011 306 314
9. P. Glasziou, L. Irwig, and J.J. Deeks When should a new test become the current reference standard? Ann Intern Med 149 2008 816 822
10. J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, J.H. Stein, and J.L. Witztum Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524
11. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-212
12. M.J. Pencina, R.B. D'Agostino, K.M. Pencina, A.C. Janssens, and P. Greenland Interpreting incremental value of markers added to risk prediction models Am J Epidemiol 176 2012 473 481
13. M.J. Pencina, R.B. D'Agostino, and R.S. Vasan Statistical methods for assessment of added usefulness of new biomarkers Clin Chem Lab Med 48 2010 1703 1711
14. M.J. Leening, M.M. Vedder, J.C. Witteman, M.J. Pencina, and E.W. Steyerberg Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide Ann Intern Med 160 2014 122 131
15. Standards of medical care in diabetes - 2013 Diabetes Care 36 suppl 1 2013 S11 S66
16. A.R. Sharrett, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, D. Catellier, and W. Patsch Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study Circulation 104 2001 1108 1113
17. W. Bao, S.R. Srinivasan, and G.S. Berenson Tracking of serum apolipoproteins A-I and B in children and young adults: the Bogalusa Heart Study J Clin Epidemiol 46 1993 609 616
18. A.B. Mazanderani, S.J. Wise, and H.D. Tildesley Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy Clin Biochem 42 2009 1218 1221
19. A.D. Sniderman, A.C. St-Pierre, B. Cantin, G.R. Dagenais, J.P. Despres, and B. Lamarche Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk Am J Cardiol 91 2003 1173 1177
20. E. Di Angelantonio, N. Sarwar, P. Perry, S. Kaptoge, K.K. Ray, A. Thompson, A.M. Wood, S. Lewington, N. Sattar, C.J. Packard, R. Collins, S.G. Thompson, and J. Danesh Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
21. S. Mora, J.E. Buring, and P.M. Ridker Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events Circulation 129 2014 553 561
22. Third report of the National cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
23. S.S. Martin, and E.D. Michos Are we moving towards concordance on the principle that lipid discordance matters? Circulation 129 2014 539 541
24. P.J. Barter, C.M. Ballantyne, R. Carmena, M. Castro Cabezas, M.J. Chapman, P. Couture, J. de Graaf, P.N. Durrington, O. Faergeman, J. Frohlich, C.D. Furberg, C. Gagne, S.M. Haffner, S.E. Humphries, I. Jungner, R.M. Krauss, P. Kwiterovich, S. Marcovina, C.J. Packard, T.A. Pearson, K.S. Reddy, R. Rosenson, N. Sarrafzadegan, A.D. Sniderman, A.F. Stalenhoef, E. Stein, P.J. Talmud, A.M. Tonkin, G. Walldius, and K.M. Williams Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel J Intern Med 259 2006 247 258
25. T.A. Jacobson Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk Mayo Clin Proc 86 2011 762 780
26. M.P. Hermans, S.A. Ahn, and M.F. Rousseau Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM Cardiovasc Diabetol 12 2013 39
27. M.P. Hermans, F.M. Sacks, S.A. Ahn, and M.F. Rousseau Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant ratio and unbiased equivalence Cardiovasc Diabetol 10 2011 20
28. L.J. Shaw, P. Raggi, E. Schisterman, D.S. Berman, and T.Q. Callister Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 228 2003 826 833